What is the treatment for a 50-year-old diabetic patient with sudden onset of headache, blurred vision, hyperglycemia (Fasting Blood Sugar (FBS) 280), and significant ketonuria (urine ketones greater than 160)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Ketoacidosis (DKA) - Immediate Treatment Required

This patient meets diagnostic criteria for diabetic ketoacidosis and requires immediate hospitalization with aggressive intravenous fluid resuscitation, continuous IV insulin therapy, and electrolyte replacement. 1, 2

Diagnostic Confirmation

This patient's presentation is consistent with DKA based on:

  • Hyperglycemia: Blood glucose 280 mg/dL (>250 mg/dL threshold) 1, 2
  • Significant ketonuria: Urine ketones >160 mg/dL (moderate to large) 1, 2
  • Clinical symptoms: Headache and blurred vision suggest metabolic derangement 3

Critical next step: Obtain immediate laboratory workup including venous blood gas, complete metabolic panel, serum ketones (preferably β-hydroxybutyrate), and calculate anion gap to confirm acidosis (pH <7.3, bicarbonate <15 mEq/L required for DKA diagnosis). 1, 4

Immediate Management Protocol

1. Fluid Resuscitation (First Priority)

Begin aggressive IV fluid replacement with 0.9% normal saline at 15-20 mL/kg/hour (approximately 1-1.5 L in the first hour for a 70 kg patient) to restore circulating volume and tissue perfusion. 1

  • Subsequent fluid choice depends on corrected serum sodium, hydration status, and urine output 1
  • Correct serum sodium for hyperglycemia: add 1.6 mEq/L for every 100 mg/dL glucose above 100 5, 1
  • Total fluid deficit should be corrected within 24 hours 4

2. Insulin Therapy

After confirming serum potassium is ≥3.3 mEq/L, start continuous IV regular insulin infusion at 0.1 units/kg/hour (approximately 5-7 units/hour for average adult) without an initial bolus. 5, 4

  • If glucose does not fall by 50 mg/dL in the first hour, double the insulin infusion rate hourly until steady decline of 50-75 mg/dL per hour is achieved 5
  • Critical pitfall to avoid: Never stop insulin infusion when glucose normalizes—ketoacidosis takes longer to resolve than hyperglycemia 1, 4

3. Glucose Management During Treatment

When blood glucose falls to 250 mg/dL, add dextrose 5% to IV fluids while continuing insulin infusion to prevent hypoglycemia and allow continued ketone clearance. 1, 4

  • Target glucose 150-200 mg/dL until DKA resolves 4
  • Continue insulin infusion until ALL resolution criteria are met (see below) 1, 4

4. Potassium Replacement (Critical)

Despite possible initial hyperkalemia, total body potassium is severely depleted in DKA. 5

Once serum potassium falls below 5.5 mEq/L and adequate urine output is confirmed, add 20-30 mEq potassium per liter of IV fluid (2/3 KCl and 1/3 KPO4) to maintain serum potassium 4-5 mEq/L. 5, 1

  • If initial potassium is <3.3 mEq/L: Delay insulin therapy and aggressively replace potassium first to prevent fatal cardiac arrhythmias 5
  • Monitor potassium every 2-4 hours 1, 4

5. Monitoring Protocol

Draw blood every 2-4 hours for glucose, electrolytes, BUN, creatinine, venous pH, and calculate anion gap. 1, 4

  • Venous pH is sufficient for monitoring (typically 0.03 units lower than arterial pH)—repeat arterial blood gases are unnecessary 1, 4
  • Measure serum β-hydroxybutyrate (not urine ketones) to monitor ketone clearance 1, 4
  • Common pitfall: Nitroprusside-based urine ketone tests only measure acetoacetate and can falsely appear to worsen during treatment as β-hydroxybutyrate converts to acetoacetate 1, 4

DKA Resolution Criteria

DKA is resolved only when ALL of the following are met: 1, 4

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap ≤12 mEq/L

Transition to Subcutaneous Insulin

Once DKA is resolved and patient can eat, initiate subcutaneous basal-bolus insulin regimen and continue IV insulin for 1-2 hours after first subcutaneous dose to ensure adequate plasma insulin levels and prevent rebound ketoacidosis. 4

Identify and Treat Precipitating Cause

The most common triggers for DKA include: 6, 3

  • Infection (most common—obtain cultures if suspected) 1
  • Insulin omission or nonadherence
  • New diagnosis of diabetes
  • Acute illness or physiologic stress

Obtain bacterial cultures (blood, urine, throat) if infection is suspected, as this is the most common precipitating factor. 1

Special Considerations for This Patient

The sudden onset headache and blurred vision warrant additional evaluation:

  • These symptoms may represent DKA-related metabolic derangement 3
  • However, rule out other acute intracranial pathology if symptoms persist after metabolic correction
  • Monitor closely for cerebral edema during treatment (rare in adults but can occur with overly aggressive fluid resuscitation) 5

Critical Pitfalls to Avoid

  • Never discontinue insulin when glucose normalizes—continue until ketoacidosis resolves (pH >7.3, bicarbonate ≥18) 1, 4
  • Never delay potassium replacement once levels fall below 5.5 mEq/L—hypokalemia can cause fatal arrhythmias 5
  • Never rely on urine ketones to monitor treatment response—use serum β-hydroxybutyrate 1, 4
  • Never give insulin if potassium <3.3 mEq/L—correct potassium first 5

References

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Ketoacidosis Diagnostic Criteria and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Guideline

Resolving Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of Diabetic Ketoacidosis in Adults: A Narrative Review.

Saudi journal of medicine & medical sciences, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.